1. Home
  2. MGTX vs BFS Comparison

MGTX vs BFS Comparison

Compare MGTX & BFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

HOLD

Current Price

$9.63

Market Cap

909.1M

Sector

Health Care

ML Signal

HOLD

BFS

Saul Centers Inc.

HOLD

Current Price

$33.76

Market Cap

809.1M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGTX
BFS
Founded
2015
1993
Country
United States
United States
Employees
N/A
98
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
909.1M
809.1M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
MGTX
BFS
Price
$9.63
$33.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
1
Target Price
$24.57
$44.00
AVG Volume (30 Days)
686.8K
42.0K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
6.92%
EPS Growth
33.02
N/A
EPS
N/A
N/A
Revenue
$81,391,000.00
N/A
Revenue This Year
$141.38
$0.30
Revenue Next Year
N/A
$5.67
P/E Ratio
N/A
$30.48
Revenue Growth
144.57
N/A
52 Week Low
$5.02
$29.16
52 Week High
$11.85
$35.45

Technical Indicators

Market Signals
Indicator
MGTX
BFS
Relative Strength Index (RSI) 51.51 48.63
Support Level $7.13 $33.14
Resistance Level $9.65 $34.99
Average True Range (ATR) 0.48 0.76
MACD -0.08 -0.11
Stochastic Oscillator 49.22 42.29

Price Performance

Historical Comparison
MGTX
BFS

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

About BFS Saul Centers Inc.

Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: Shopping Centers segment, which contribute the maximum portion of total revenue; and mixed-use properties.Mixed-Use Properties segment include office, retail and multi-family residential use.

Share on Social Networks: